Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1127
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04811560 | A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) | ||
| NCT02933762 | A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and Plasma | ||
| NCT01442532 | A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam | ||
| NCT06663319 | A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers | ||
| NCT01273493 | A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction | ||
| NCT05661604 | A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness | ||
| NCT03362736 | An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease | ||
| NCT00397033 | Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder. | ||
| NCT01128452 | Safety and Efficacy of EVT 101 in Treatment-Resistant Depression | ||
| NCT03242278 | Real-world Dosing Patterns of Rivaroxaban in the United States | ||
| NCT02090543 | BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies | ||
| NCT03126097 | A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females | ||
| NCT02659735 | A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation | ||
| NCT03926013 | A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors | ||
| NCT02342249 | Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects | ||
| NCT02260674 | A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease | ||
| NCT05275023 | An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants | ||
| NCT01965613 | A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum | ||
| NCT05014360 | A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis | ||
| NCT01110382 | A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections | ||
| NCT04552197 | A Study of JNJ-64251330 in Healthy Participants | ||
| NCT03551782 | A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT01800006 | Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region | ||
| NCT01877915 | A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure | ||
| NCT04176718 | Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM | ||
| NCT04960124 | A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants | ||
| NCT05379634 | A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies | ||
| NCT02715011 | Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) | ||
| NCT05421663 | A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma | ||
| NCT01804686 | A Long-term Extension Study of PCI-32765 (Ibrutinib) | ||
| NCT02489305 | Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD) | ||
| NCT04297072 | Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists | ||
| NCT07321873 | A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis | ||
| NCT02201251 | A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy | ||
| NCT04452994 | Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple Myeloma | ||
| NCT01270945 | Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis. | ||
| NCT05498428 | A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer | ||
| NCT02498392 | An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress | ||
| NCT03185819 | Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide | ||
| NCT04410094 | A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult Participants | ||
| NCT06881251 | A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) | ||
| NCT01051531 | A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia | ||
| NCT02951845 | Study to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076 in Healthy Participants | ||
| NCT02905331 | Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis | ||
| NCT02949206 | A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Male Subjects | ||
| NCT00752232 | Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease | ||
| NCT04033458 | A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male Participants | ||
| NCT02203032 | A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab | ||
| NCT03596645 | A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis | ||
| NCT05338775 | A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma |
